Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
NCT ID: NCT00898170
Last Updated: 2009-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2008-05-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Single Session of Intermittent Hypoxia on Hematological Variables
NCT05898685
Effects of Heating Transfusion on Brain Function
NCT01930305
Correlation, Accuracy, Precision and Practicability of Zero Heat Flux Temperature Monitoring
NCT02031159
Induced Hypothermia in Cardiac Arrest Patients Rescued by Extracorporeal Cardiopulmonary Resuscitation.
NCT00965016
The Effect of Partial and Complete Sleep Deprivation on Heat Tolerance
NCT01596543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hypertension. We studied the effect of myoma removal on hypertension and erythropoietin level to evaluate this hypothesis.
Patients \& Methods:
In this single centered prospective cohort study, in twenty eight patients who were candidates for myomectomy due to myoma, 24 hour holter monitoring of blood pressure and serum erythropoietin were checked before and 6 weeks after hysterectomy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
myoma, with or without hypertension
those with myoma with or without hypertension in holter monitoring
myoma removal
surgical removal of myoma by hysterectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
myoma removal
surgical removal of myoma by hysterectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* operable
* hysterectomy is indicated
Exclusion Criteria
* inoperable patients
* other secondary cases of hypertension
22 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shiraz University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
shiraz university of medical sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
javad kojuri, M.D.
Role: PRINCIPAL_INVESTIGATOR
Shiraz University of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiology Ward Shiraz University of Medical Sciences
Shiraz, Fars, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
88-2505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.